Milestone Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.

About MIST

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. 

CEO
Joseph G. Oliveto
CEOJoseph G. Oliveto
Employees
33
Employees33
Headquarters
Montréal, Québec
HeadquartersMontréal, Québec
Founded
2003
Founded2003
Employees
33
Employees33

MIST Key Statistics

Market cap
169.06M
Market cap169.06M
Price-Earnings ratio
-2.29
Price-Earnings ratio-2.29
Dividend yield
Dividend yield
Average volume
3.28M
Average volume3.28M
High today
$2.00
High today$2.00
Low today
$1.94
Low today$1.94
Open price
$1.98
Open price$1.98
Volume
2.16M
Volume2.16M
52 Week high
$3.06
52 Week high$3.06
52 Week low
$0.6254
52 Week low$0.6254

Stock Snapshot

As of today, Milestone Pharmaceuticals(MIST) shares are valued at $1.99. The company's market cap stands at 169.06M, with a P/E ratio of -2.29.

During the trading session on 2026-01-24, Milestone Pharmaceuticals(MIST) shares reached a daily high of $2.00 and a low of $1.94. At a current price of $1.99, the stock is +2.6% higher than the low and still -0.5% under the high.

Trading volume for Milestone Pharmaceuticals(MIST) stock has reached 2.16M, versus its average volume of 3.28M.

The stock's 52-week range extends from a low of $0.63 to a high of $3.06.

The stock's 52-week range extends from a low of $0.63 to a high of $3.06.

People also own

Based on the portfolios of people who own MIST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.